TTK Healthcare [TTKHLTCARE] vs Kopran [KOPRAN] Detailed Stock Comparison

TTK Healthcare

NSE
Loading...

Kopran

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: TTK Healthcare wins in 11 metrics, Kopran wins in 9 metrics, with 0 ties. TTK Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTTK HealthcareKopranBetter
P/E Ratio (TTM)25.7924.12Kopran
Price-to-Book Ratio1.531.62TTK Healthcare
Debt-to-Equity Ratio2.2728.51TTK Healthcare
PEG Ratio-0.44-0.73Kopran
EV/EBITDA27.0313.67Kopran
Profit Margin (TTM)7.69%5.58%TTK Healthcare
Operating Margin (TTM)0.22%7.30%Kopran
EBITDA Margin (TTM)0.22%7.30%Kopran
Return on Equity7.67%7.44%TTK Healthcare
Return on Assets (TTM)6.37%4.57%TTK Healthcare
Free Cash Flow (TTM)$-168.16M$-169.77MTTK Healthcare
Dividend Yield0.74%1.74%Kopran
1-Year Return-28.09%-43.97%TTK Healthcare
Price-to-Sales Ratio (TTM)1.991.35Kopran
Enterprise Value$7.74B$9.47BKopran
EV/Revenue Ratio0.941.52TTK Healthcare
Gross Profit Margin (TTM)55.03%36.84%TTK Healthcare
Revenue per Share (TTM)$580$130TTK Healthcare
Earnings per Share (Diluted)$44.68$7.23TTK Healthcare
Beta (Stock Volatility)0.280.28Kopran
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

TTK Healthcare vs Kopran Stock Performance Analysis

Loading Price Chart...

TTK Healthcare
Kopran
TTK Healthcare Stock Overview | Kopran Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
TTK Healthcare-0.72%-2.66%0.24%-9.50%-1.96%-17.55%
Kopran4.12%-3.91%10.93%-5.79%-6.24%-17.43%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
TTK Healthcare-28.09%21.98%161.51%46.44%179.35%308.57%
Kopran-43.97%6.92%92.78%209.74%346.87%169.56%

News Based Sentiment: TTK Healthcare vs Kopran

TTK Healthcare

News based Sentiment: MIXED

September presented a mixed bag for TTK Healthcare, with impressive revenue growth overshadowed by a significant drop in profitability and a change in the promoter group. These conflicting signals, coupled with share price volatility, create a complex investment picture requiring careful monitoring of upcoming financial results and leadership developments.

View TTK Healthcare News Sentiment Analysis

Kopran

News based Sentiment: MIXED

September presented a mixed bag for Kopran, with disappointing financial results countered by a significant promoter stake increase and fluctuating stock performance. While the Q1 results raise concerns, the promoter confidence and varying analyst targets offer a glimmer of optimism, making it a month of notable, but not entirely positive, developments.

View Kopran News Sentiment Analysis

Performance & Financial Health Analysis: TTK Healthcare vs Kopran

MetricTTKHLTCAREKOPRAN
Market Information
Market Cap i₹16.28B₹8.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,890304,189
90 Day Avg. Volume i3,256302,170
Last Close₹1,150.60₹182.85
52 Week Range₹1,101.05 - ₹1,755.00₹154.06 - ₹334.35
% from 52W High-34.44%-45.31%
All-Time High₹1,893.95 (Sep 09, 2024)₹370.45 (Dec 27, 2021)
% from All-Time High-39.25%-50.64%
Growth Metrics
Quarterly Revenue Growth0.09%-0.03%
Quarterly Earnings Growth-0.59%-0.33%
Financial Health
Profit Margin (TTM) i0.08%0.06%
Operating Margin (TTM) i0.00%0.07%
Return on Equity (TTM) i0.08%0.07%
Debt to Equity (MRQ) i2.2728.51
Cash & Liquidity
Book Value per Share (MRQ)₹753.73₹107.66
Cash per Share (MRQ)₹605.17₹5.35
Operating Cash Flow (TTM) i₹338.96M₹376.89M
Levered Free Cash Flow (TTM) i₹816.57M₹385.52M
Dividends
Last 12-Month Dividend Yield i0.74%1.74%
Last 12-Month Dividend i₹10.00₹3.00

Valuation & Enterprise Metrics Analysis: TTK Healthcare vs Kopran

MetricTTKHLTCAREKOPRAN
Price Ratios
P/E Ratio (TTM) i25.7924.12
Forward P/E iN/A30.75
PEG Ratio i-0.44-0.73
Price to Sales (TTM) i1.991.35
Price to Book (MRQ) i1.531.62
Market Capitalization
Market Capitalization i₹16.28B₹8.76B
Enterprise Value i₹7.74B₹9.47B
Enterprise Value Metrics
Enterprise to Revenue i0.941.52
Enterprise to EBITDA i27.0313.67
Risk & Other Metrics
Beta i0.280.28
Book Value per Share (MRQ) i₹753.73₹107.66

Financial Statements Comparison: TTK Healthcare vs Kopran

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TTKHLTCAREKOPRAN
Revenue/Sales i₹2.26B₹1.35B
Cost of Goods Sold i₹1.02B₹854.04M
Gross Profit i₹1.25B₹498.12M
Research & Development iN/AN/A
Operating Income (EBIT) i₹4.88M₹98.71M
EBITDA i₹206.11M₹166.86M
Pre-Tax Income i₹176.54M₹98.89M
Income Tax i₹46.54M₹24.40M
Net Income (Profit) i₹129.99M₹74.49M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TTKHLTCAREKOPRAN
Cash & Equivalents i₹90.06M₹194.73M
Total Current Assets i₹11.04B₹5.10B
Total Current Liabilities i₹2.11B₹2.89B
Long-Term Debt i₹17.73M₹164.83M
Total Shareholders Equity i₹10.65B₹5.18B
Retained Earnings i₹9.40B₹1.82B
Property, Plant & Equipment i₹808.99M₹408,000

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TTKHLTCAREKOPRAN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTTKHLTCAREKOPRAN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,890304,189
Average Daily Volume (90 Day) i3,256302,170
Shares Outstanding i14.13M48.29M
Float Shares i3.27M24.27M
% Held by Insiders i0.77%0.48%
% Held by Institutions i0.03%0.00%

Dividend Analysis & Yield Comparison: TTK Healthcare vs Kopran

MetricTTKHLTCAREKOPRAN
Last 12-Month Dividend i₹10.00₹3.00
Last 12-Month Dividend Yield i0.74%1.74%
3-Year Avg Annual Dividend i₹13.33₹3.00
3-Year Avg Dividend Yield i0.85%1.30%
3-Year Total Dividends i₹40.00₹9.00
Ex-Dividend DateJul 18, 2025Sep 04, 2025